PharVision Advisers LLC Makes New Investment in Chimera Investment Co. (NYSE:CIM)

PharVision Advisers LLC bought a new stake in shares of Chimera Investment Co. (NYSE:CIM) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 12,729 shares of the real estate investment trust’s stock, valued at approximately $178,000.

A number of other hedge funds also recently made changes to their positions in CIM. Quarry LP grew its position in shares of Chimera Investment by 1,691.7% during the 4th quarter. Quarry LP now owns 3,243 shares of the real estate investment trust’s stock valued at $45,000 after acquiring an additional 3,062 shares during the period. New Age Alpha Advisors LLC purchased a new position in Chimera Investment in the fourth quarter valued at approximately $56,000. Hillsdale Investment Management Inc. bought a new position in Chimera Investment during the fourth quarter valued at $65,000. Summit Securities Group LLC purchased a new stake in Chimera Investment in the fourth quarter worth $111,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Chimera Investment in the fourth quarter valued at $170,000. 48.44% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Gerard Creagh acquired 12,500 shares of Chimera Investment stock in a transaction that occurred on Tuesday, March 11th. The stock was bought at an average price of $13.31 per share, with a total value of $166,375.00. Following the completion of the purchase, the director now owns 138,127 shares in the company, valued at approximately $1,838,470.37. The trade was a 9.95% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.91% of the company’s stock.

Chimera Investment Trading Down 0.7%

Shares of CIM stock opened at $12.98 on Friday. The stock has a market capitalization of $1.05 billion, a price-to-earnings ratio of 12.01 and a beta of 1.76. The company’s fifty day simple moving average is $12.35 and its two-hundred day simple moving average is $13.69. Chimera Investment Co. has a 1 year low of $9.85 and a 1 year high of $16.89. The company has a debt-to-equity ratio of 2.82, a current ratio of 0.06 and a quick ratio of 3.03.

Chimera Investment (NYSE:CIM) last announced its quarterly earnings results on Thursday, May 8th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. The company had revenue of $69.22 million during the quarter, compared to analysts’ expectations of $72.07 million. Chimera Investment had a return on equity of 7.00% and a net margin of 20.28%. As a group, analysts anticipate that Chimera Investment Co. will post 1.57 earnings per share for the current year.

Chimera Investment Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st were given a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 11.41%. The ex-dividend date was Monday, March 31st. Chimera Investment’s dividend payout ratio is presently 98.67%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. Wall Street Zen upgraded Chimera Investment from a “hold” rating to a “buy” rating in a research note on Thursday, May 15th. Royal Bank of Canada raised shares of Chimera Investment to a “moderate buy” rating in a report on Friday, March 14th. Finally, UBS Group upgraded shares of Chimera Investment from a “neutral” rating to a “buy” rating and increased their target price for the stock from $11.50 to $15.00 in a research report on Wednesday, May 14th. Two research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.50.

Chimera Investment Profile

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.